NCT00455026View on ClinicalTrials.gov

Effect of Remifentanil on Electroencephalographic BAR Index During Propofol Anaesthesia

PHASE1CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions
Depth of Anaesthesia
Interventions
DRUG

remifentanil

target effect site concentration during induction

Trial Locations (2)

3050

Royal Melbourne Hospital, Parkville

3123

Swinburne University, Hawthorn

Sponsors

Lead Sponsor

Melbourne Health

Collaborators (1)

Biopharmica Limited
All Listed Sponsors
collaborator

Biopharmica Limited

INDUSTRY

lead

Melbourne Health

OTHER

NCT00455026 - Effect of Remifentanil on Electroencephalographic BAR Index During Propofol Anaesthesia | Biotech Hunter | Biotech Hunter